In tumor specimens from responders, we observed smaller numbers of IER3+ CAFs and NRG1+ malignant cells in randomly selected fields and a dispersed distribution pattern of IER3+ CAFs inside tumor bed. The gene discussed is NRG1; the disease is neoplasm.